Claris Lifesciences, one of the largest sterile injectables pharmaceutical companies in India, witnessed a rise in share price on Friday after it announced a substantial rise in consolidated net profit for the quarter ended June 2015.  During the quarter, the profit of the company rose 31.07% to Rs 202.86 million from Rs 154.78 million  in the same quarter last year.

Revenues for the quarter  rose 22.58% to Rs 1,919.41 million, compared with Rs 1,566 million for the prior year period.

Shares of Claris Lifesciences are trading at Rs 229.30, up Rs 8.7, or 3.94% at the Bombay Stock Exchange (BSE) on Friday at 9:41 a.m.

The scrip has touched an intra-day high of Rs 234.90 and low of Rs 228.20. The total volume of shares traded at the BSE is 85,593.